Inogen Announces Second Quarter 2019 Financial Results and Updates 2019 Guidance
Summary
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2019. These sales to the Company’s private label partner declined primarily due to one large national homecare provider who had significantly reduced orders in the second quarter of 2019 as compared to the same period in 2018. The Company has entered into a definitive agreement to acquire New Aera, Inc. (“New Aera”), an innovative developer and manufacturer of portable non-invasive ventilators for people suffering from various chronic lung diseases. In addition, the Company believes that this technology can be used to help a portion of the over 200 million chronic obstructive pulmonary disease (“COPD”) patients worldwide who are not on oxygen therapy and are willing to pay out-of-pocket, to reduce breathlessness particularly during exercise. Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.